CN Stock MarketDetailed Quotes

Yili Chuanning Biotechnology (301301)

Watchlist
  • 11.04
  • -0.35-3.07%
Market Closed Jan 16 15:00 CST
24.62BMarket Cap26.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Yili Chuanning Biotechnology (301301) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Assets
Current assets
Money funds
19.80%747.73M
-12.98%808.48M
7.07%952.64M
43.03%1.09B
-43.37%624.17M
-21.57%929.12M
-13.74%889.72M
-53.37%760.94M
278.95%1.1B
128.80%1.18B
Transactional financial assets
----
--4.35K
--190.33M
----
--613K
----
----
----
----
--0
Notes receivable and accounts receivable
-5.68%971.77M
9.65%1.03B
19.10%978.37M
25.56%939.3M
13.59%1.03B
0.66%937.99M
-19.57%821.45M
-14.76%748.09M
-15.35%907M
-4.44%931.86M
-Accounts receivable
-5.68%971.77M
9.65%1.03B
19.10%978.37M
25.56%939.3M
13.59%1.03B
0.66%937.99M
-19.57%821.45M
-14.76%748.09M
-15.35%907M
-4.44%931.86M
Other receivables (including interest and dividends)
-37.67%860.97K
-10.98%1.25M
-37.63%863.9K
-15.82%531.44K
-31.12%1.38M
-25.96%1.4M
-17.33%1.39M
-75.64%631.29K
-18.01%2.01M
27.42%1.89M
-Other receivable
----
-10.98%1.25M
----
----
----
-25.96%1.4M
----
-75.64%631.29K
----
27.42%1.89M
Advance payment
48.06%490.58M
3.44%108.2M
-20.03%104.8M
98.46%89.11M
-8.13%331.33M
-5.19%104.6M
-0.66%131.04M
-47.17%44.9M
4.24%360.64M
-0.24%110.33M
Inventories
19.49%1.07B
19.46%1.1B
-14.25%1.17B
-19.95%1.34B
2.28%896.83M
-0.54%920.62M
27.56%1.36B
21.16%1.68B
-20.73%876.82M
-24.32%925.62M
Receivable financing
-51.07%564.08M
-29.35%797.18M
-13.75%960.46M
-3.42%632.97M
79.93%1.15B
79.64%1.13B
28.13%1.11B
21.48%655.4M
-18.53%640.75M
15.07%628.07M
Other current assets
245.92%175.04M
25.75%73.11M
21.92%62.16M
-25.89%51.9M
97.46%50.6M
360.54%58.14M
663.00%50.98M
1,020.40%70.04M
741.80%25.63M
336.25%12.62M
Total current assets
-1.62%4.02B
-4.01%3.92B
1.09%4.42B
4.75%4.14B
4.42%4.09B
7.51%4.08B
5.81%4.37B
-12.62%3.96B
8.56%3.91B
12.38%3.79B
Non Current assets
Other equity investment
-0.47%24.88M
-0.47%24.88M
-0.47%24.88M
--24.88M
--25M
--25M
--25M
----
----
----
Other non-current financial assets
--30M
--30M
--30M
--30M
----
----
----
----
----
----
Long-term equity investment
805.28%146.82M
125.16%37.1M
461.84%37.9M
132.98%15.8M
137.69%16.22M
139.97%16.48M
-2.28%6.74M
-2.10%6.78M
70.90%6.82M
--6.87M
Fixed assets
----
2.44%5.04B
----
----
----
-5.98%4.92B
----
-5.96%5.14B
----
-7.75%5.23B
Constru in process
----
-56.30%329.43M
----
----
----
473.17%753.83M
----
794.48%537.8M
----
253.34%131.52M
Intangible assets
-2.91%233.98M
-2.66%238.96M
-8.11%231.04M
-8.59%235.83M
-8.89%241M
-9.44%245.48M
-9.43%251.45M
-8.86%257.99M
-8.67%264.53M
-8.48%271.08M
Development expenditure
--1M
--1M
--1M
----
----
----
----
----
----
--940.18K
Goodwill
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
0.00%1.37M
Long deferred expense
-50.00%878.25K
-44.44%1.1M
-40.00%1.32M
-36.36%1.54M
-33.33%1.76M
-30.77%1.98M
-28.57%2.2M
-29.02%2.42M
-29.39%2.63M
-29.70%2.85M
Deferred tax assets
-16.29%23.66M
-11.53%23.93M
4.77%22.31M
-3.47%20.9M
41.38%28.26M
62.40%27.05M
69.29%21.3M
90.99%21.65M
116.31%19.99M
72.62%16.65M
Usufruct assets
-6.74%473.32M
-4.89%477.73M
153.38%481.59M
153.75%485.99M
162.43%507.5M
138.62%502.29M
-11.65%190.07M
1,582.76%191.52M
1,528.99%193.38M
1,602.92%210.5M
Other non current assets
-13.57%41.1M
48.52%35.4M
30.71%32.67M
53.65%33.25M
-71.92%47.55M
-73.42%23.83M
-26.45%24.99M
20.45%21.64M
280.13%169.34M
98.45%89.67M
Total non current assets
-2.39%6.31B
-4.24%6.24B
1.79%6.32B
3.67%6.41B
5.49%6.46B
9.26%6.52B
3.67%6.21B
5.45%6.18B
2.82%6.13B
-1.88%5.97B
Total assets
-2.09%10.33B
-4.15%10.16B
1.50%10.73B
4.09%10.55B
5.07%10.55B
8.58%10.6B
4.55%10.57B
-2.42%10.14B
4.99%10.04B
3.21%9.76B
Liabilities
Current liabilities
Short term loan
12.48%360.14M
-72.00%210.14M
-75.30%210.15M
-75.30%210.15M
-51.38%320.18M
10.46%750.6M
-3.38%850.75M
-13.09%850.68M
-21.66%658.47M
-19.17%679.53M
Transactional financial liabilities
--226.4K
----
----
----
----
-93.96%256.1K
-49.14%551.43K
--31.5K
-77.66%665.89K
316.82%4.24M
Notes payable and accounts payable
-4.89%655.31M
-15.36%663.54M
-18.49%803.12M
-11.38%895.44M
-8.97%689M
20.49%783.99M
68.23%985.26M
36.45%1.01B
20.13%756.93M
8.32%650.65M
-Notes payable
----
----
-48.89%150M
-48.89%150M
----
--0
--293.46M
166.79%293.46M
-36.36%70M
--70M
-Accounts payable
-4.89%655.31M
-15.36%663.54M
-5.59%653.12M
3.97%745.44M
0.30%689M
35.02%783.99M
18.12%691.79M
13.71%716.96M
32.08%686.93M
-3.34%580.65M
Contract liabilities
-76.01%18.63M
153.20%46.63M
-51.21%27.01M
130.86%66.82M
-0.41%77.65M
-86.26%18.42M
356.11%55.36M
-23.84%28.94M
706.35%77.97M
887.83%134.06M
Advance receipts
----
----
----
----
----
----
----
----
----
--0
Salaries payable
8.09%28.85M
5.05%27.62M
10.02%27.32M
23.52%36.98M
15.94%26.69M
9.92%26.29M
10.31%24.83M
13.04%29.94M
31.87%23.02M
11.43%23.92M
Taxs payable
-20.92%92.63M
-25.32%88.17M
-5.33%132.36M
168.02%103.01M
24.61%117.14M
14.19%118.06M
102.66%139.8M
-26.34%38.43M
71.79%94M
129.13%103.39M
Other payable (including interest and dividends)
-35.15%40.16M
-43.84%31.89M
-14.19%28.85M
-60.39%12.54M
118.43%61.92M
66.70%56.78M
27.01%33.62M
82.85%31.66M
908.80%28.35M
59.27%34.06M
-Interest payable
----
----
----
----
----
----
--0
----
----
----
-Dividend payable
----
----
----
----
----
----
--0
----
----
----
-Other payable
----
-43.84%31.89M
----
----
----
66.70%56.78M
--33.62M
82.85%31.66M
----
59.27%34.06M
Non current liabilities due within one year
-42.46%402.49M
101.56%737.63M
93.37%740.58M
13.81%617.06M
-8.25%699.54M
-52.02%365.96M
-55.10%382.99M
-36.15%542.16M
21.23%762.47M
21.26%762.79M
Other current liabilities
4,048.95%202.64M
200.27%5.71M
-61.89%2.68M
61.20%5.55M
-51.34%4.88M
-89.06%1.9M
346.38%7.02M
-30.31%3.44M
702.46%10.04M
891.28%17.37M
Total current liabilities
-9.81%1.8B
-14.65%1.81B
-20.49%1.97B
-23.20%1.95B
-17.20%2B
-11.94%2.12B
1.15%2.48B
-6.34%2.54B
10.21%2.41B
10.82%2.41B
Current liabilities
Long term loan
----
----
--0
-59.14%146M
-43.24%393M
-6.11%650M
-52.79%483M
-74.98%357.33M
-69.00%692.33M
-69.00%692.33M
Estimate liabilities
-48.35%2.82M
-6.71%3M
115.63%3.04M
----
2.64%5.47M
-5.84%3.22M
-43.84%1.41M
--77.9K
--5.33M
--3.41M
Deferred tax liabilities
-91.77%11.72K
-8.81%86.23K
----
----
-83.86%142.43K
-84.12%94.56K
-97.09%20.7K
268.49%307.28K
--882.58K
--595.63K
Long term deferred income
18.63%110.92M
3.71%98.07M
14.85%94.56M
10.47%92.51M
13.11%93.5M
71.57%94.56M
148.16%82.34M
144.56%83.74M
246.14%82.66M
123.37%55.11M
Lease liabilities
-1.82%464.45M
0.34%459.84M
135.24%455.67M
139.81%451.12M
154.20%473.06M
129.31%458.29M
-10.67%193.7M
1,743.84%188.12M
1,681.27%186.09M
1,779.90%199.86M
Total non current liabilities
-40.09%578.2M
-53.49%560.99M
-27.25%553.28M
9.54%689.63M
-0.22%965.17M
26.79%1.21B
-40.41%760.47M
-57.25%629.58M
-57.34%967.3M
-58.06%951.32M
Total liabilities
-19.68%2.38B
-28.73%2.37B
-22.07%2.53B
-16.69%2.64B
-12.34%2.96B
-0.98%3.33B
-13.08%3.24B
-24.27%3.17B
-24.16%3.38B
-24.35%3.36B
Shareholders equity
Paid-in capital
0.13%2.23B
0.13%2.23B
0.20%2.23B
0.20%2.23B
0.20%2.23B
0.20%2.23B
0.00%2.22B
0.00%2.22B
11.14%2.22B
11.14%2.22B
Capital reserve funds
0.56%3.3B
0.62%3.3B
0.86%3.29B
1.00%3.28B
1.16%3.28B
1.34%3.28B
0.91%3.26B
0.69%3.25B
33.45%3.24B
33.09%3.23B
Surplus reserve funds
88.79%325.32M
88.79%325.32M
88.79%325.32M
88.79%325.32M
132.85%172.32M
132.85%172.32M
132.85%172.32M
132.85%172.32M
117.80%74M
117.80%74M
Retained profit
9.60%2.07B
21.18%1.91B
40.98%2.35B
56.88%2.06B
69.98%1.89B
83.21%1.58B
95.20%1.67B
93.71%1.31B
73.96%1.11B
58.56%862.36M
Less:Treasury stock
----
----
----
----
----
----
--0
----
----
----
Other composite income
---99.34K
---99.34K
---99.34K
---99.34K
----
----
--0
----
----
----
Ordinary risk reserve funds
----
----
----
----
----
----
--0
----
----
----
Specific reserves
----
----
----
----
----
----
--0
----
----
----
Shareholders equity without minority interests
4.70%7.93B
7.04%7.77B
11.86%8.19B
13.46%7.9B
13.81%7.57B
13.51%7.26B
14.74%7.32B
12.18%6.96B
30.34%6.65B
27.67%6.39B
Minority interests
35.55%25.54M
43.82%18.55M
46.06%18.82M
46.28%18.83M
73.32%18.84M
114.86%12.9M
114.65%12.88M
114.47%12.87M
81.12%10.87M
-0.00%6M
Total shareholder equity
4.77%7.95B
7.10%7.79B
11.92%8.21B
13.52%7.92B
13.90%7.59B
13.60%7.27B
14.83%7.33B
12.28%6.97B
30.40%6.66B
27.63%6.4B
Total liabilityies and equity
-2.09%10.33B
-4.15%10.16B
1.50%10.73B
4.09%10.55B
5.07%10.55B
8.58%10.6B
4.55%10.57B
-2.42%10.14B
4.99%10.04B
3.21%9.76B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Assets
Current assets
Money funds 19.80%747.73M-12.98%808.48M7.07%952.64M43.03%1.09B-43.37%624.17M-21.57%929.12M-13.74%889.72M-53.37%760.94M278.95%1.1B128.80%1.18B
Transactional financial assets ------4.35K--190.33M------613K------------------0
Notes receivable and accounts receivable -5.68%971.77M9.65%1.03B19.10%978.37M25.56%939.3M13.59%1.03B0.66%937.99M-19.57%821.45M-14.76%748.09M-15.35%907M-4.44%931.86M
-Accounts receivable -5.68%971.77M9.65%1.03B19.10%978.37M25.56%939.3M13.59%1.03B0.66%937.99M-19.57%821.45M-14.76%748.09M-15.35%907M-4.44%931.86M
Other receivables (including interest and dividends) -37.67%860.97K-10.98%1.25M-37.63%863.9K-15.82%531.44K-31.12%1.38M-25.96%1.4M-17.33%1.39M-75.64%631.29K-18.01%2.01M27.42%1.89M
-Other receivable -----10.98%1.25M-------------25.96%1.4M-----75.64%631.29K----27.42%1.89M
Advance payment 48.06%490.58M3.44%108.2M-20.03%104.8M98.46%89.11M-8.13%331.33M-5.19%104.6M-0.66%131.04M-47.17%44.9M4.24%360.64M-0.24%110.33M
Inventories 19.49%1.07B19.46%1.1B-14.25%1.17B-19.95%1.34B2.28%896.83M-0.54%920.62M27.56%1.36B21.16%1.68B-20.73%876.82M-24.32%925.62M
Receivable financing -51.07%564.08M-29.35%797.18M-13.75%960.46M-3.42%632.97M79.93%1.15B79.64%1.13B28.13%1.11B21.48%655.4M-18.53%640.75M15.07%628.07M
Other current assets 245.92%175.04M25.75%73.11M21.92%62.16M-25.89%51.9M97.46%50.6M360.54%58.14M663.00%50.98M1,020.40%70.04M741.80%25.63M336.25%12.62M
Total current assets -1.62%4.02B-4.01%3.92B1.09%4.42B4.75%4.14B4.42%4.09B7.51%4.08B5.81%4.37B-12.62%3.96B8.56%3.91B12.38%3.79B
Non Current assets
Other equity investment -0.47%24.88M-0.47%24.88M-0.47%24.88M--24.88M--25M--25M--25M------------
Other non-current financial assets --30M--30M--30M--30M------------------------
Long-term equity investment 805.28%146.82M125.16%37.1M461.84%37.9M132.98%15.8M137.69%16.22M139.97%16.48M-2.28%6.74M-2.10%6.78M70.90%6.82M--6.87M
Fixed assets ----2.44%5.04B-------------5.98%4.92B-----5.96%5.14B-----7.75%5.23B
Constru in process -----56.30%329.43M------------473.17%753.83M----794.48%537.8M----253.34%131.52M
Intangible assets -2.91%233.98M-2.66%238.96M-8.11%231.04M-8.59%235.83M-8.89%241M-9.44%245.48M-9.43%251.45M-8.86%257.99M-8.67%264.53M-8.48%271.08M
Development expenditure --1M--1M--1M--------------------------940.18K
Goodwill 0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M0.00%1.37M
Long deferred expense -50.00%878.25K-44.44%1.1M-40.00%1.32M-36.36%1.54M-33.33%1.76M-30.77%1.98M-28.57%2.2M-29.02%2.42M-29.39%2.63M-29.70%2.85M
Deferred tax assets -16.29%23.66M-11.53%23.93M4.77%22.31M-3.47%20.9M41.38%28.26M62.40%27.05M69.29%21.3M90.99%21.65M116.31%19.99M72.62%16.65M
Usufruct assets -6.74%473.32M-4.89%477.73M153.38%481.59M153.75%485.99M162.43%507.5M138.62%502.29M-11.65%190.07M1,582.76%191.52M1,528.99%193.38M1,602.92%210.5M
Other non current assets -13.57%41.1M48.52%35.4M30.71%32.67M53.65%33.25M-71.92%47.55M-73.42%23.83M-26.45%24.99M20.45%21.64M280.13%169.34M98.45%89.67M
Total non current assets -2.39%6.31B-4.24%6.24B1.79%6.32B3.67%6.41B5.49%6.46B9.26%6.52B3.67%6.21B5.45%6.18B2.82%6.13B-1.88%5.97B
Total assets -2.09%10.33B-4.15%10.16B1.50%10.73B4.09%10.55B5.07%10.55B8.58%10.6B4.55%10.57B-2.42%10.14B4.99%10.04B3.21%9.76B
Liabilities
Current liabilities
Short term loan 12.48%360.14M-72.00%210.14M-75.30%210.15M-75.30%210.15M-51.38%320.18M10.46%750.6M-3.38%850.75M-13.09%850.68M-21.66%658.47M-19.17%679.53M
Transactional financial liabilities --226.4K-----------------93.96%256.1K-49.14%551.43K--31.5K-77.66%665.89K316.82%4.24M
Notes payable and accounts payable -4.89%655.31M-15.36%663.54M-18.49%803.12M-11.38%895.44M-8.97%689M20.49%783.99M68.23%985.26M36.45%1.01B20.13%756.93M8.32%650.65M
-Notes payable ---------48.89%150M-48.89%150M------0--293.46M166.79%293.46M-36.36%70M--70M
-Accounts payable -4.89%655.31M-15.36%663.54M-5.59%653.12M3.97%745.44M0.30%689M35.02%783.99M18.12%691.79M13.71%716.96M32.08%686.93M-3.34%580.65M
Contract liabilities -76.01%18.63M153.20%46.63M-51.21%27.01M130.86%66.82M-0.41%77.65M-86.26%18.42M356.11%55.36M-23.84%28.94M706.35%77.97M887.83%134.06M
Advance receipts --------------------------------------0
Salaries payable 8.09%28.85M5.05%27.62M10.02%27.32M23.52%36.98M15.94%26.69M9.92%26.29M10.31%24.83M13.04%29.94M31.87%23.02M11.43%23.92M
Taxs payable -20.92%92.63M-25.32%88.17M-5.33%132.36M168.02%103.01M24.61%117.14M14.19%118.06M102.66%139.8M-26.34%38.43M71.79%94M129.13%103.39M
Other payable (including interest and dividends) -35.15%40.16M-43.84%31.89M-14.19%28.85M-60.39%12.54M118.43%61.92M66.70%56.78M27.01%33.62M82.85%31.66M908.80%28.35M59.27%34.06M
-Interest payable --------------------------0------------
-Dividend payable --------------------------0------------
-Other payable -----43.84%31.89M------------66.70%56.78M--33.62M82.85%31.66M----59.27%34.06M
Non current liabilities due within one year -42.46%402.49M101.56%737.63M93.37%740.58M13.81%617.06M-8.25%699.54M-52.02%365.96M-55.10%382.99M-36.15%542.16M21.23%762.47M21.26%762.79M
Other current liabilities 4,048.95%202.64M200.27%5.71M-61.89%2.68M61.20%5.55M-51.34%4.88M-89.06%1.9M346.38%7.02M-30.31%3.44M702.46%10.04M891.28%17.37M
Total current liabilities -9.81%1.8B-14.65%1.81B-20.49%1.97B-23.20%1.95B-17.20%2B-11.94%2.12B1.15%2.48B-6.34%2.54B10.21%2.41B10.82%2.41B
Current liabilities
Long term loan ----------0-59.14%146M-43.24%393M-6.11%650M-52.79%483M-74.98%357.33M-69.00%692.33M-69.00%692.33M
Estimate liabilities -48.35%2.82M-6.71%3M115.63%3.04M----2.64%5.47M-5.84%3.22M-43.84%1.41M--77.9K--5.33M--3.41M
Deferred tax liabilities -91.77%11.72K-8.81%86.23K---------83.86%142.43K-84.12%94.56K-97.09%20.7K268.49%307.28K--882.58K--595.63K
Long term deferred income 18.63%110.92M3.71%98.07M14.85%94.56M10.47%92.51M13.11%93.5M71.57%94.56M148.16%82.34M144.56%83.74M246.14%82.66M123.37%55.11M
Lease liabilities -1.82%464.45M0.34%459.84M135.24%455.67M139.81%451.12M154.20%473.06M129.31%458.29M-10.67%193.7M1,743.84%188.12M1,681.27%186.09M1,779.90%199.86M
Total non current liabilities -40.09%578.2M-53.49%560.99M-27.25%553.28M9.54%689.63M-0.22%965.17M26.79%1.21B-40.41%760.47M-57.25%629.58M-57.34%967.3M-58.06%951.32M
Total liabilities -19.68%2.38B-28.73%2.37B-22.07%2.53B-16.69%2.64B-12.34%2.96B-0.98%3.33B-13.08%3.24B-24.27%3.17B-24.16%3.38B-24.35%3.36B
Shareholders equity
Paid-in capital 0.13%2.23B0.13%2.23B0.20%2.23B0.20%2.23B0.20%2.23B0.20%2.23B0.00%2.22B0.00%2.22B11.14%2.22B11.14%2.22B
Capital reserve funds 0.56%3.3B0.62%3.3B0.86%3.29B1.00%3.28B1.16%3.28B1.34%3.28B0.91%3.26B0.69%3.25B33.45%3.24B33.09%3.23B
Surplus reserve funds 88.79%325.32M88.79%325.32M88.79%325.32M88.79%325.32M132.85%172.32M132.85%172.32M132.85%172.32M132.85%172.32M117.80%74M117.80%74M
Retained profit 9.60%2.07B21.18%1.91B40.98%2.35B56.88%2.06B69.98%1.89B83.21%1.58B95.20%1.67B93.71%1.31B73.96%1.11B58.56%862.36M
Less:Treasury stock --------------------------0------------
Other composite income ---99.34K---99.34K---99.34K---99.34K----------0------------
Ordinary risk reserve funds --------------------------0------------
Specific reserves --------------------------0------------
Shareholders equity without minority interests 4.70%7.93B7.04%7.77B11.86%8.19B13.46%7.9B13.81%7.57B13.51%7.26B14.74%7.32B12.18%6.96B30.34%6.65B27.67%6.39B
Minority interests 35.55%25.54M43.82%18.55M46.06%18.82M46.28%18.83M73.32%18.84M114.86%12.9M114.65%12.88M114.47%12.87M81.12%10.87M-0.00%6M
Total shareholder equity 4.77%7.95B7.10%7.79B11.92%8.21B13.52%7.92B13.90%7.59B13.60%7.27B14.83%7.33B12.28%6.97B30.40%6.66B27.63%6.4B
Total liabilityies and equity -2.09%10.33B-4.15%10.16B1.50%10.73B4.09%10.55B5.07%10.55B8.58%10.6B4.55%10.57B-2.42%10.14B4.99%10.04B3.21%9.76B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -